SCPH Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.52%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

scPharmaceuticals Insider Trading History Chart

scPharmaceuticals Share Price & Price History

^$3.39

▲ +0.08 (2.42%)

As of 12/20/2024 06:16 PM ET

Days: 30 | 90 | 365

$2 Trillion Disappears Because of Fed's Secretive New Move

From Stansberry Research | Ad

$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being carried out by the Fed that has nothing to do with lowering or raising interest rates... but could soon have an enormous impact on your wealth.

Click here to see his new research now.

scPharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/25/2022	Orbimed Advisors Llc	Major Shareholder	Buy	762,380	$5.25	$4,002,495.00	5,328,328
10/10/2022	5Am Partners Iv, Llc	Major Shareholder	Sell	562,466	$4.09	$2,300,485.94	92,983
10/6/2022	5Am Partners Iv, Llc	Major Shareholder	Sell	37,534	$5.02	$188,420.68	112,000
9/6/2022	5Am Partners Iv, Llc	Major Shareholder	Sell	26,622	$5.52	$146,953.44	120,062
4/11/2022	5Am Partners Iv, Llc	Major Shareholder	Sell	270,000	$5.00	$1,350,000.00	120,966

Nvidia’s Bold Move: Tackling Tech’s $1 Trillion Crisis

From Weiss Ratings | Ad

Taiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as 4,744%. Now, if you’re like everybody else, you want to know what Nvidia’s doing next … and who they’re going to partner with …

Find out details on these three critical Nvidia partners immediately.

SEC Filings (Institutional Ownership Changes) for scPharmaceuticals (NASDAQ:SCPH)

89.52% of scPharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

scPharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/25/2024	Sanctuary Advisors LLC	16,555	$75K	0.0%	N/A	0.033%
11/20/2024	Virtu Financial LLC	10,105	$46K	0.0%	N/A	0.020%
11/19/2024	Barclays PLC	40,644	$0.19M	0.0%	+317.2%	0.081%
11/16/2024	Geode Capital Management LLC	643,342	$2.93M	0.0%	+10.6%	1.286%
11/15/2024	Barclays PLC	40,644	$0.19M	0.0%	+317.2%	0.081%
11/15/2024	XTX Topco Ltd	27,169	$0.12M	0.0%	N/A	0.054%
11/15/2024	Jane Street Group LLC	23,485	$0.11M	0.0%	-46.2%	0.047%
11/15/2024	State Street Corp	682,135	$3.11M	0.0%	+5.2%	1.363%
11/14/2024	Captrust Financial Advisors	18,539	$85K	0.0%	+32.2%	0.037%
11/14/2024	Walleye Capital LLC	475,555	$2.17M	0.0%	+27.0%	0.951%
11/14/2024	Suvretta Capital Management LLC	2,049,009	$9.34M	0.3%	N/A	4.096%
11/14/2024	Stonepine Capital Management LLC	778,874	$3.55M	2.2%	+84.7%	1.557%
11/14/2024	MetLife Investment Management LLC	16,974	$77K	0.0%	+135.0%	0.034%
11/13/2024	Rubric Capital Management LP	4,775,000	$21.77M	0.4%	+35.5%	9.544%
11/13/2024	BNP Paribas Financial Markets	5,753	$26K	0.0%	+116.9%	0.011%
11/13/2024	The Manufacturers Life Insurance Company	12,411	$57K	0.0%	N/A	0.025%
11/12/2024	Charles Schwab Investment Management Inc.	75,890	$0.35M	0.0%	-4.2%	0.152%
11/8/2024	King Luther Capital Management Corp	2,225,790	$10.15M	0.0%	+0.9%	4.449%
11/7/2024	Thrivent Financial for Lutherans	1,048,938	$4.78M	0.0%	+1.4%	2.097%
10/28/2024	Rice Hall James & Associates LLC	621,665	$2.84M	0.2%	+25.0%	1.724%
8/21/2024	Stonepine Capital Management LLC	421,703	$1.83M	1.7%	-5.6%	1.170%
8/14/2024	Bank of Montreal Can	351,806	$1.54M	0.0%	N/A	0.976%
8/13/2024	Thrivent Financial for Lutherans	1,034,072	$4.50M	0.0%	-3.1%	2.868%
8/13/2024	King Luther Capital Management Corp	2,205,140	$9.59M	0.0%	+51.8%	6.116%
8/9/2024	Renaissance Technologies LLC	221,000	$0.96M	0.0%	-6.3%	0.613%
8/9/2024	Dimensional Fund Advisors LP	135,080	$0.59M	0.0%	-18.7%	0.375%
8/8/2024	Rice Hall James & Associates LLC	497,227	$2.16M	0.1%	+76.9%	1.379%
8/7/2024	AIGH Capital Management LLC	3,504,365	$15.24M	4.7%	+3.4%	9.720%
7/31/2024	Balanced Rock Investment Advisors LLC	63,130	$0.28M	0.2%	+10.3%	0.175%
7/26/2024	Bank of New York Mellon Corp	86,101	$0.38M	0.0%	+15.1%	0.239%
7/18/2024	Assenagon Asset Management S.A.	72,692	$0.32M	0.0%	+266.7%	0.202%
5/20/2024	Virtu Financial LLC	17,895	$90K	0.0%	N/A	0.050%
5/16/2024	Kennedy Capital Management LLC	219,754	$1.10M	0.0%	-1.5%	0.610%
5/13/2024	Balanced Rock Investment Advisors LLC	57,248	$0.29M	0.2%	+9.2%	0.159%
5/10/2024	Perkins Capital Management Inc.	10,600	$53K	0.0%	N/A	0.029%
5/9/2024	Mitsubishi UFJ Asset Management Co. Ltd.	20,634	$0.10M	0.0%	-21.3%	0.057%
4/24/2024	Assenagon Asset Management S.A.	19,822	$100K	0.0%	N/A	0.055%
4/23/2024	Rice Hall James & Associates LLC	281,105	$1.41M	0.1%	+247.0%	0.780%
4/10/2024	Thomasville National Bank	36,800	$0.19M	0.0%	+11.5%	0.102%
2/14/2024	Rubric Capital Management LP	3,500,000	$21.95M	0.5%	+29.0%	9.760%
2/13/2024	Tower Research Capital LLC TRC	5,518	$35K	0.0%	-54.0%	0.015%
2/12/2024	IPG Investment Advisors LLC	12,000	$75K	0.0%	N/A	0.033%
2/12/2024	AIGH Capital Management LLC	3,106,795	$19.48M	7.7%	+40.8%	8.664%
2/9/2024	King Luther Capital Management Corp	1,393,525	$8.74M	0.0%	+48.8%	3.886%
2/9/2024	Worth Venture Partners LLC	771,344	$4.84M	2.6%	+42.9%	2.151%
2/8/2024	Mitsubishi UFJ Asset Management Co. Ltd.	26,202	$0.17M	0.0%	-43.5%	0.073%
1/16/2024	Raymond James & Associates	87,049	$0.55M	0.0%	+6.6%	0.243%
11/30/2023	American Century Companies Inc.	840,830	$5.99M	0.0%	-1.8%	2.345%
11/21/2023	Walleye Capital LLC	426,520	$3.04M	0.0%	-23.8%	1.189%
11/15/2023	Tejara Capital Ltd	101,414	$0.72M	0.4%	N/A	0.283%
11/15/2023	Rubric Capital Management LP	2,713,287	$19.32M	0.7%	+234.3%	7.566%
11/15/2023	Worth Venture Partners LLC	539,665	$3.84M	2.3%	+5.3%	1.505%
11/15/2023	Laurion Capital Management LP	148,815	$1.06M	0.0%	-9.8%	0.415%
11/14/2023	Rubric Capital Management LP	2,713,287	$19.32M	0.7%	+234.3%	7.566%
11/13/2023	Tejara Capital Ltd	101,414	$0.72M	0.5%	N/A	0.283%
11/13/2023	AIGH Capital Management LLC	2,207,009	$15.71M	7.4%	+7.6%	6.155%
11/9/2023	Cowen AND Company LLC	1,795,647	$12.79M	0.9%	-2.3%	5.007%
11/2/2023	Rice Hall James & Associates LLC	87,071	$0.62M	0.0%	+9.1%	0.243%
10/24/2023	Bank of New York Mellon Corp	74,856	$0.53M	0.0%	-28.7%	0.209%
10/24/2023	Raymond James & Associates	81,672	$0.58M	0.0%	+5.7%	0.228%
9/21/2023	Barclays PLC	5,756	$58K	0.0%	-92.2%	0.016%
8/24/2023	Alberta Investment Management Corp	111,410	$1.14M	0.0%	N/A	0.311%
8/14/2023	Jefferies Financial Group Inc.	831,000	$8.47M	0.1%	-36.9%	2.317%
8/14/2023	Thrivent Financial for Lutherans	655,020	$6.67M	0.0%	N/A	1.827%
8/11/2023	Rubric Capital Management LP	811,517	$8.27M	0.4%	N/A	2.269%
8/10/2023	King Luther Capital Management Corp	558,925	$5.70M	0.0%	+34.8%	1.563%
8/9/2023	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	47,383	$0.48M	0.0%	N/A	0.132%
8/7/2023	Cowen AND Company LLC	1,837,918	$18.73M	1.6%	-34.5%	5.138%
8/4/2023	American International Group Inc.	13,900	$0.14M	0.0%	N/A	0.039%
7/25/2023	Raymond James & Associates	77,252	$0.79M	0.0%	+10.6%	0.216%
7/24/2023	Rice Hall James & Associates LLC	79,830	$0.81M	0.0%	N/A	0.223%
5/15/2023	RTW Investments LP	3,297,843	$29.91M	0.6%	N/A	9.220%
5/15/2023	AIGH Capital Management LLC	2,075,797	$18.83M	6.9%	-18.6%	5.803%
5/11/2023	King Luther Capital Management Corp	414,500	$3.76M	0.0%	N/A	1.159%
5/9/2023	Cowen AND Company LLC	2,807,562	$25.47M	3.0%	N/A	7.849%
5/9/2023	Tower Research Capital LLC TRC	16,982	$0.15M	0.0%	+17.5%	0.047%
5/8/2023	ClariVest Asset Management LLC	80,784	$0.73M	0.0%	-27.4%	0.226%
5/4/2023	Barclays PLC	73,448	$0.67M	0.0%	N/A	0.205%
5/3/2023	Jump Financial LLC	47,109	$0.43M	0.0%	+49.1%	0.132%
5/1/2023	CM Wealth Advisors LLC	21,357	$0.20M	0.0%	N/A	0.060%
4/14/2023	Raymond James & Associates	69,851	$0.63M	0.0%	+35.0%	0.195%
2/16/2023	AIGH Capital Management LLC	2,550,234	$18.29M	6.0%	+236.9%	9.297%
2/15/2023	Armistice Capital LLC	2,148,000	$15.40M	0.3%	-13.8%	7.830%
2/14/2023	RA Capital Management L.P.	1,856,904	$13.31M	0.3%	N/A	6.770%
2/14/2023	683 Capital Management LLC	26,424	$0.19M	0.0%	N/A	0.096%
2/7/2023	Commonwealth Equity Services LLC	29,210	$0.21M	0.0%	+88.1%	0.106%
2/1/2023	Bank of Montreal Can	69,600	$0.50M	0.0%	N/A	0.254%
1/10/2023	FNY Investment Advisers LLC	21,500	$0.15M	0.2%	N/A	0.078%
1/10/2023	Thomasville National Bank	33,000	$0.24M	0.0%	+20.0%	0.120%
11/14/2022	Worth Venture Partners LLC	188,522	$1.23M	0.8%	-43.9%	0.687%
11/14/2022	Armistice Capital LLC	2,492,000	$16.25M	0.3%	-7.7%	9.084%
11/14/2022	Wolverine Trading LLC	23,282	$0.14M	0.0%	+69.1%	0.085%
11/14/2022	Boothbay Fund Management LLC	40,751	$0.27M	0.0%	-52.3%	0.149%
11/9/2022	Group One Trading L.P.	27,060	$0.18M	0.0%	+1,946.9%	0.099%
10/26/2022	Belvedere Trading LLC	120,706	$0.66M	0.0%	-49.5%	0.441%
10/19/2022	Ritholtz Wealth Management	15,000	$98K	0.0%	N/A	0.055%
10/3/2022	Thomasville National Bank	27,500	$0.18M	0.0%	+83.3%	0.100%
8/12/2022	Ikarian Capital LLC	884,008	$4.26M	0.8%	-8.9%	3.230%
7/21/2022	Belvedere Trading LLC	239,219	$1.27M	0.0%	+48.7%	0.874%
7/19/2022	Commonwealth Equity Services LLC	15,530	$74K	0.0%	N/A	0.057%

Data available starting January 2016

scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. Its lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion due to fluid overload in adults with chronic heart failure and kidney disease, as well as consists of subcutaneous loop diuretic that delivers IV equivalent diuresis at home; and FUROSCIX On-Body Infusor, a drug-device combination product consisting of FUROSCIX. The company's product pipeline also includes SCP-111 (furosemide injection), an investigational pH neutral aqueous furosemide formulation that is being developed for subcutaneous administration outside of the hospital setting, including patient self-administration in the home; and SCP-111 Autoinjector, an investigational single-entity, drug-device combination product candidate consisting of a prefilled syringe containing SCP-111, preloaded into a commercially available, fixed single dose, disposable, two step mechanical autoinjector. It has a collaboration agreement with West Pharmaceutical Services, Inc. The company was incorporated in 2013 and is headquartered in Burlington, Massachusetts.

Today's Range

Now: $3.39

$3.24

$3.45

50 Day Range

MA: $3.81

$3.14

$4.53

52 Week Range

Now: $3.39

$3.08

$6.71

Volume

2,870,967 shs

Average Volume

294,288 shs

Market Capitalization

$169.64 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.14

Who are the major institutional investors of scPharmaceuticals?: scPharmaceuticals' top institutional investors include:
Rubric Capital Management LP — 9.54%
King Luther Capital Management Corp — 4.45%
Suvretta Capital Management LLC — 4.10%
Thrivent Financial for Lutherans — 2.10%
Stonepine Capital Management LLC — 1.56%
State Street Corp — 1.36%
Learn More about top institutional investors of scPharmaceuticals stock.
Which major investors are selling scPharmaceuticals stock?: During the last quarter, SCPH stock was sold by these institutional investors:
Jane Street Group LLC
Charles Schwab Investment Management Inc.
Which major investors are buying scPharmaceuticals stock?: During the previous quarter, SCPH stock was purchased by institutional investors including:
Suvretta Capital Management LLC
Rubric Capital Management LP
Stonepine Capital Management LLC
Rice Hall James & Associates LLC
Walleye Capital LLC
Geode Capital Management LLC
State Street Corp
Barclays PLC